Literature DB >> 9402381

Quinolone arthropathy in animals versus children.

J E Burkhardt1, J N Walterspiel, U B Schaad.   

Abstract

The use of quinolones in children and accumulation of data on the pharmacodynamics of these drugs have been limited and delayed by concern regarding their chondrotoxicity. A comprehensive review of the findings in animals compared with the cumulative published findings in children and adolescents (>7,000 to date) allows the conclusion that such concern is not justified. Prospective controlled studies in children are justifiable in view of a continuing lack of correlation between findings in juvenile animals and those in children and because of the selected therapeutic advantages of the current and newer quinolones.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402381     DOI: 10.1086/516119

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Gatifloxacin Therapy in Otitis Media in Children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

2.  Provider and health care system response to a bioterrorist attack.

Authors:  J D Malone
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-07

3.  In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model.

Authors:  Yuichi Fukuda; Katsunori Yanagihara; Hideaki Ohno; Yasuhito Higashiyama; Yoshitsugu Miyazaki; Kazuhiro Tsukamoto; Yoichi Hirakata; Kazunori Tomono; Yohei Mizuta; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

Authors:  Sumathi Sivapalasingam; Jennifer M Nelson; Kevin Joyce; Mike Hoekstra; Frederick J Angulo; Eric D Mintz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  The place of quinolones in paediatric anti-infective therapy.

Authors:  J Langley
Journal:  Paediatr Child Health       Date:  2001-07       Impact factor: 2.253

Review 6.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

7.  Pharmacokinetics of gatifloxacin in infants and children.

Authors:  Edmund V Capparelli; Michael D Reed; John S Bradley; Gregory L Kearns; Richard F Jacobs; Bharat D Damle; Jeffrey L Blumer; Dennis M Grasela
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  4-(3-Carb-oxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-7-quinol-yl)-1-methyl-piper-azin-ium picrate.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; Divya N Shetty; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-27

9.  The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model.

Authors:  Jason M Sansone; Norman J Wilsman; Ellen M Leiferman; James Conway; Paul Hutson; Kenneth J Noonan
Journal:  J Pediatr Orthop       Date:  2009-03       Impact factor: 2.324

10.  Colonic diverticular abscess presenting as chronic diarrhea: a case report.

Authors:  Nasser Ebrahimi Daryani; Mohammad Reza Keramati; Peiman Habibollahi; Mohammad Reza Pashaei; Nafiseh Ansarinejad; Hossein Ajdarkosh
Journal:  Cases J       Date:  2009-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.